Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Case Studies01:22

Case Studies

13.5K
There are many research methods available to psychologists in their efforts to understand, describe, and explain behavior and the cognitive and biological processes that underlie it.
13.5K
The Stanford Prison Experiment03:20

The Stanford Prison Experiment

24.7K
The famous and controversial Stanford Prison Experiment, conducted by social psychologist Philip Zimbardo and his colleagues at Stanford University, demonstrated the power of social roles, social norms, and scripts.
24.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeting CD162 for Life-Threatening Cutaneous Chronic Graft-Versus-Host Disease: A Case Report.

EJHaem·2026
Same author

System-Level Redesign of an Allogeneic Hematopoietic Cell Transplantation Program Associated with High 1-Year Survival and Reduced Cost.

Transplantation and cellular therapy·2026
Same author

Right time: stopping multiple myeloma maintenance.

Blood·2025
Same author

Phase 1 clinical trial of B-Cell Maturation Antigen (BCMA) NEX-T® Chimeric Antigen Receptor (CAR) T cell therapy CC-98633/BMS-986354 in participants with triple-class exposed multiple myeloma.

Leukemia·2025
Same author

Correction: Randomized Phase II Trial of Dendritic Cell/Myeloma Fusion Vaccine with Lenalidomide Maintenance after Upfront Autologous Hematopoietic Cell Transplantation for Multiple Myeloma: BMT CTN 1401.

Clinical cancer research : an official journal of the American Association for Cancer Research·2024
Same author

Alliance A061202: ixazomib, pomalidomide, and dexamethasone for patients with lenalidomide-refractory MM in first relapse.

Blood advances·2024

Related Experiment Video

Updated: Feb 4, 2026

Biology of Microbial Communities - Interview
14:42

Biology of Microbial Communities - Interview

Published on: May 28, 2007

9.1K

Interview with Dr Philip McCarthy.

Philip McCarthy1

  • 1Department of Medicine, Blood & Marrow Transplant, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.

International Journal of Hematologic Oncology
|October 11, 2018
PubMed
Summary
This summary is machine-generated.

Hematopoietic stem cell transplant (HSCT) research focuses on novel allogeneic and autologous approaches for hematologic disorders. A Phase III trial showed lenalidomide maintenance after autologous HSCT improves survival for multiple myeloma patients.

Keywords:
autologous and allogeneic hematopoietic stem cell transplantcellular therapiesgraft-versus-host diseasemultiple myeloma

More Related Videos

Studies of Bacterial Chemotaxis Using Microfluidics - Interview
10:35

Studies of Bacterial Chemotaxis Using Microfluidics - Interview

Published on: May 28, 2007

8.7K
Microbial Communities in Nature and Laboratory - Interview
29:13

Microbial Communities in Nature and Laboratory - Interview

Published on: May 28, 2007

6.8K

Related Experiment Videos

Last Updated: Feb 4, 2026

Biology of Microbial Communities - Interview
14:42

Biology of Microbial Communities - Interview

Published on: May 28, 2007

9.1K
Studies of Bacterial Chemotaxis Using Microfluidics - Interview
10:35

Studies of Bacterial Chemotaxis Using Microfluidics - Interview

Published on: May 28, 2007

8.7K
Microbial Communities in Nature and Laboratory - Interview
29:13

Microbial Communities in Nature and Laboratory - Interview

Published on: May 28, 2007

6.8K

Area of Science:

  • Oncology
  • Hematology
  • Stem Cell Transplantation

Background:

  • Philip McCarthy, MD, is a seasoned expert in Hematopoietic Stem Cell Transplantation (HSCT) with over 20 years of experience.
  • His research interests lie in developing innovative allogeneic (allo) and autologous (auto) HSCT strategies for hematologic malignancies.
  • The Roswell Park Comprehensive Cancer Center team focuses on systematic HSCT evaluation and treatment, aiming to reduce mortality and toxicity.

Purpose of the Study:

  • To investigate novel intensive and reduced-intensity allogeneic and autologous HSCT approaches.
  • To improve patient outcomes and decrease treatment-related toxicity in hematologic disorders.
  • To evaluate the efficacy of lenalidomide maintenance therapy post-autologous HSCT for multiple myeloma.

Main Methods:

  • Conducting clinical trials, including Phase III studies like CALGB 100104.
  • Directing clinical and translational HSCT research.
  • Systematic evaluation and treatment protocols for HSCT patients.

Main Results:

  • The CALGB 100104 trial demonstrated improved progression-free and overall survival in multiple myeloma patients receiving lenalidomide maintenance after autologous HSCT.
  • The Roswell Park team has developed a systematic approach to HSCT, focusing on predicting and minimizing treatment-related mortality.

Conclusions:

  • Lenalidomide maintenance therapy after autologous HSCT is a viable strategy to improve survival for multiple myeloma patients.
  • Ongoing research aims to further refine HSCT techniques and mitigate complications, enhancing patient outcomes in hematologic disorders.